Interim Management Statement

British & American Investment Trust PLC Interim Management Statement - 3 months to 30 September 2013 To the members of British & American Investment Trust PLC This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose. This interim management statement relates to the period from 1 July 2013 to 30 September 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified. Investment objective To invest predominantly in investment trusts and other leading UK quoted companies to achieve a balance of income and growth. Benchmark FTSE All-Share Index and FTSE 100 Index. Material developments On 29 August 2013 the company reported its Half Year results to 30 June 2013. An interim ordinary dividend of 2.7p is to be paid on 7 November 2013 to shareholders on the register at 11 October 2013. A dividend of 1.75p per share is to be paid to preference shareholders on 7 November 2013. Twenty largest equity holdings at 30 September 2013 (group basis) % Geron Corporation 25.27 Rit Capital Partners 11.55 Dunedin Income Growth 9.31 British Assets Trust 6.96 Prudential 6.40 St. James's Place Global Equity 6.24 Biotime Inc NPV 4.41 Scottish & American Investment Company 3.51 Invesco Income Growth Trust 2.83 Alliance Trust 2.62 F&C Asset Management - 6.75% FRN Sub. Bonds 2026 1.86 Merchants Trust 1.71 Royal & Sun Alliance Insurance Group - 7.375% Cum. irred. preference shares £1 1.69 Shires Income 1.63 Rothschilds Continuation Finance - 9% Perp. Sub. Gtd. Loan Notes 1.58 Earthport 1.25 Barclays Bank - 9% PIB Capital Bonds 0.85 Jupiter Income Trust 0.73 Matrix Chatham EZT (unquoted) 0.70 Emblaze Systems 0.57 Total 91.67 Sector allocation as at 30 September 2013 (group basis) % Investment Trusts (equities) 41.95 Biomedical - USA 25.27 Unit Trusts 6.96 Life Assurance 6.83 Biotechnology 4.46 Software and computer services 1.83 Leisure and hotels 0.56 Telecommunications 0.40 Other Financial 0.37 Support services 0.26 Media 0.12 Pharmaceuticals 0.08 Financial services 0.06 Overseas 0.01 Fixed Interest Stocks excluding Preference 3.43 Derivatives - traded options 2.95 Preference 2.17 Property Units 1.20 Permanent Interest Bearing 1.02 Fixed Interest Stocks (unquoted) 0.07 Total 100.00 Key facts Performance As at As at As at As at As at 30 30 30 30 30 September September September September September 2013 2013 2012 2010 2008 Year to 1 year 3 years 5 years date Total assets (000) 28,723 Short term borrowings £nil Actual gearing nil % NAV (p) 82.1 FTSE All-Share 3,443.85 Share price (p) 85.5 14.0% 18.8% 9.6% 3.6% Premium/(discount) 4.1% 2.7% -15.5% -10.9% Dividend yield 8.89% 10.28% 8.85% 7.76% Ongoing charges (year ended 31/12/12) 2.47% As at 30 September 2013 1 year 3 years 5 years Value of £100 invested (dividends reinvested) 131.0 147.2 164.9 FTSE ALL-Share 118.9 133.4 166.2 Total Return; Net Income Reinvested, GBP. Source: Walker Crips Stockbrokers Limited and Fundamental Data Limited. Source: Association of Investment Companies and Morningstar. The Board is not aware of any significant events or transactions which have occurred between 30 September 2013 and the date of publication of this interim management statement which would have a material impact on the financial position of the Company. For latest performance information, please refer to the Company's website, www.baitgroup.co.uk. For British & American Investment Trust PLC 5 November 2013
UK 100

Latest directors dealings